|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 215/36 | (2006.01) |
| A61P 7/06 | (2006.01) | ||
| A61K 31/4709 | (2006.01) |
| (11) | Number of the document | 3713919 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18821779.8 |
| Date of filing the European patent application | 2018-11-21 | |
| (97) | Date of publication of the European application | 2020-09-30 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-02 |
| (46) | Date of publication of the claims translation | 2023-10-10 |
| (86) | Number | PCT/US2018/062197 |
| Date | 2018-11-21 |
| (87) | Number | WO 2019/104134 |
| Date | 2019-05-31 |
| (30) | Number | Date | Country code |
| 201762589822 P | 2017-11-22 | US | |
| 201862691709 P | 2018-06-29 | US |
| (72) |
SIZEMORE, Jacob, P. , US
GUO, Liting , CN
MIRMEHRABI, Mahmoud , CA
SU, Yeqing , CA
|
| (73) |
Agios Pharmaceuticals, Inc. ,
88 Sidney Street, Cambridge, MA 02139,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kristalinės N-(4-(4-(ciklopropilmetil)piperazin-1-karbonil)fenil)chinolin-8- sulfonamido formos |
| CRYSTALLINE FORMS OF N-(4-(4-(CYCLOPROPYLMETHYL) PIPERAZINE-1-CARBONYL)PHENYL)QUINOLINE-8-SULFONAMIDE |
| Payment date | Validity (years) | Amount | |
| 2024-10-31 | 7 | 162.00 EUR |
| 2025-11-21 |